A certain starkness marks the entrance to Curadev Pharma Private Limited. Freshly painted, the walls are bare; the reception desk is unmanned. The company does mostly science and doesn’t need a front desk; not yet. Ask them about the emptiness and co-founders Arjun Surya and Manish Tandon look at the ceiling and wistfully discuss how the AstraZeneca headquarters in Sweden had the hanging molecular structure of Omeprazole, the multi-billion-dollar anti-ulcer drug, greet visitors. “Maybe, one day, when one of our molecules becomes successful, we’ll have its molecular structure (mural) hanging here,” they say, almost in…
Curadev’s drug discovery slot machine
Most will call it madness: Selling your house to raise money and thinking Venture Capital firms will buy the dream of discovering new drugs from India. But Curadev lived that madness; hit a jackpot and is probably onto its next one. A rare success story, without investor money
Sign up to read this story for free right now
Stories on The Ken are available only for its subscribers. Join us now to get instant access.
Complete access to all stories on The Ken.
Rs. 2,750/year or Rs. 900/quarter
All free stories published, past and upcoming
Have an account? Login now